The abstract is read at the publisher; the summary is JClub's.
Hepatopulmonary syndrome and portopulmonary hypertension are distinct pulmonary vascular complications in liver transplantation candidates, and both substantially increase morbidity and mortality.
- Why it matters: Standard exception policies for these conditions are important because they may affect access to liver transplantation, yet PoPH management and transplant benefit remain debated.
- What they did: The Eurotransplant experience was evaluated for model for end-stage liver disease standard exceptions specifically for hepatopulmonary syndrome and portopulmonary hypertension.
- The result: The study frames how these exception models relate to outcomes in candidates with HPS versus PoPH, supporting ongoing discussion about transplant roles, especially for PoPH.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.